PMID- 16386646 OWN - NLM STAT- MEDLINE DCOM- 20060922 LR - 20111117 IS - 0198-8859 (Print) IS - 0198-8859 (Linking) VI - 66 IP - 10 DP - 2005 Oct TI - HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. PG - 1050-6 AB - An increase in cervical intraepithelial neoplasia (CIN) has been described in American Indian women in New Mexico. Differences in human leukocyte antigen (HLA) alleles have been reported in cervical intraepithelial neoplasia (CIN) compared with controls in other populations. We investigated HLA alleles and CIN in Southwest American Indian women. The case control study included 89 women with biopsy-proven CIN II/III (diagnosed November 1994 through October 1997) and 271 similar women with normal cervical epithelium from the same clinics. DRB1, DQB1, and DPB1 alleles were determined using DNA typing techniques. DQA1 and HLA-A allele typing was included for some subjects (randomly chosen n = 37 and n = 163 cases and controls, respectively). We found a decreased risk of CIN with DRB1*1402 (OR 0.5, 95% CI 0.3-0.9) and an increased risk with DRB1*1501 (OR 2.7, 95% CI 0.9-7.3). Additionally, DQA1*0102 was associated with increased risk (OR 4.5, 95% CI 1.3-5.3) and HLA-A*02 with decreased risk (OR 0.4, CI 0.2-0.9). Our findings are discussed along with studies in other populations. FAU - Schiff, Melissa A AU - Schiff MA AD - Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA 98104, USA. FAU - Apple, Raymond J AU - Apple RJ FAU - Lin, Patricia AU - Lin P FAU - Nelson, J Lee AU - Nelson JL FAU - Wheeler, Cosette M AU - Wheeler CM FAU - Becker, Thomas M AU - Becker TM LA - eng GR - R01-CA-55348/CA/NCI NIH HHS/United States GR - T32-CA09168/CA/NCI NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20051025 PL - United States TA - Hum Immunol JT - Human immunology JID - 8010936 RN - 0 (HLA-A Antigens) RN - 0 (HLA-DP Antigens) RN - 0 (HLA-DP beta-Chains) RN - 0 (HLA-DPB1 antigen) RN - 0 (HLA-DQ Antigens) RN - 0 (HLA-DQ alpha-Chains) RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DQA1 antigen) RN - 0 (HLA-DQB1 antigen) RN - 0 (HLA-DR Antigens) RN - 0 (HLA-DRB1 Chains) RN - 0 (Membrane Glycoproteins) SB - IM MH - Adolescent MH - Adult MH - Alleles MH - Case-Control Studies MH - Confidence Intervals MH - Female MH - Gene Frequency MH - Genetic Predisposition to Disease MH - HLA-A Antigens/*genetics MH - HLA-DP Antigens/genetics MH - HLA-DP beta-Chains MH - HLA-DQ Antigens/genetics MH - HLA-DQ alpha-Chains MH - HLA-DQ beta-Chains MH - HLA-DR Antigens/genetics MH - HLA-DRB1 Chains MH - Haplotypes MH - Humans MH - Indians, North American MH - Membrane Glycoproteins/genetics MH - Middle Aged MH - Neoplasm Staging MH - New Mexico MH - Odds Ratio MH - Risk Factors MH - Uterine Cervical Neoplasms/ethnology/*genetics/pathology EDAT- 2006/01/03 09:00 MHDA- 2006/09/23 09:00 CRDT- 2006/01/03 09:00 PHST- 2005/03/10 00:00 [received] PHST- 2005/09/14 00:00 [accepted] PHST- 2006/01/03 09:00 [pubmed] PHST- 2006/09/23 09:00 [medline] PHST- 2006/01/03 09:00 [entrez] AID - S0198-8859(05)00421-0 [pii] AID - 10.1016/j.humimm.2005.09.002 [doi] PST - ppublish SO - Hum Immunol. 2005 Oct;66(10):1050-6. doi: 10.1016/j.humimm.2005.09.002. Epub 2005 Oct 25.